期刊
STEM CELL REPORTS
卷 3, 期 3, 页码 489-501出版社
CELL PRESS
DOI: 10.1016/j.stemcr.2014.07.009
关键词
-
资金
- BBSRC
- LLR
- MRC
- Wellcome Trust
- BBSRC [BB/D01347X/1, BB/H008780/1] Funding Source: UKRI
- MRC [G0900962, G0500950] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/H008780/1, BB/D01347X/1] Funding Source: researchfish
- Medical Research Council [G0900962, G0500950] Funding Source: researchfish
Definitive hematopoietic stem cells (HSCs) develop in the aorta gonad mesonephros (AGM) region in a stepwise manner. Type I pre-HSCs express CD41 but lack CD45 expression, which is subsequently upregulated in type II pre-HSCs prior to their maturation into definitive HSCs. Here, using ex vivo modeling of HSC development, we identify precursors of definitive HSCs in the trunk of the embryonic day 9.5 (E9.5) mouse embryo. These precursors, termed here pro-HSCs, are less mature than type I and II pre-HSCs. Although pro-HSCs are CD41(+), they lack the CD43 marker, which is gradually upregulated in the developing HSC lineage. We show that stem cell factor (SCF), but not interleukin-3 (IL-3), is a major effector of HSC maturation during E9-E10. This study extends further the previously established hierarchical organization of the developing HSC lineage and presents it as a differentially regulated four-step process and identifies additional targets that could facilitate the generation of transplantable HSCs from pluripotent cells for clinical needs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据